HMB-45 is crucial for distinguishing between melanocytic lesions and other types of tumors. Its specificity for melanocytic cells makes it an invaluable tool in the diagnosis and classification of pigmented lesions. This antibody helps differentiate benign nevi from malignant melanomas, guiding appropriate clinical management.